The Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment on patients in the east of the country, the health ministry said on Tuesday, the first time it has been deployed against an active outbreak.
The outbreak in eastern Congo’s North Kivu province has now spread to neighbouring Ituri province, where a person who was a confirmed case died after returning home from the flare-up’s epicentre in the North Kivu town of Mangina, the ministry said in a statement.
Five new cases have been confirmed, the statement said, bringing the total number of cases to 57 — 30 confirmed and 27 that are considered probable. Forty-one people are believed to have died in all from the haemorrhagic fever.
The mAb114 treatment was developed in the United States by the National Institutes of Health using the antibodies of the survivor of an Ebola outbreak in the western Congolese city of Kikwit in 1995.
It was 100 per cent effective when tested on monkeys.
"Fiscal measures will complement monetary control tools and diesel prices will fall further below 1000…
Everton sit just three points above the relegation zone with nine games left in their…
"I'm getting tired of putting up with being dragged by everyone in my life and…
The governor said he remained resolute in steering Kaduna to the path of progress using…
Spurs have now come from behind to win in four of their last five home…
The Founder of The Chair Centre Group and former Chairperson of First Bank of Nigeria…